Human Mixtard 70/30 Suspension for Injection 100IU/ml

By Human Mixtard

Rx

10ml Suspension for Injection in a Vial

Composition icon

Composition

Insulin Isophane/NPH(70%) + Human Insulin/Soluble Insulin(30%)

Manufacturer - Novo Nordisk India Pvt Ltd icon

Manufacturer - Novo Nordisk India Pvt Ltd

Plot No.32, 47-50, EPIP Area, Whitefield, Bangalore - 560 066

Expires on or after icon

Expires on or after

April, 2026

About Human Mixtard 70/30 Suspension for Injection 100IU/ml

Human Mixtard 70/30 Suspension for Injection 100IU/ml is a combination of two types of insulin – an intermediate-acting and a short-acting one, used in the treatment of diabetes mellitus. This medication is essential for improving blood sugar control in both adults and children with diabetes. It is crucial to follow your doctor's instructions regarding the correct way to inject it under the skin, usually done 15 minutes before a meal or up to 20 minutes after starting a meal.

Human Mixtard 70/30 Injection is just one part of a comprehensive diabetes treatment plan that should include a healthy diet, regular exercise, and possibly weight reduction as advised by your healthcare provider. Monitoring your blood sugar levels regularly and sharing the results with your doctor is vital for determining the right dosage for you. Common side effects of this medication include low blood sugar levels, injection site reactions, potential weight gain, rash, swelling, and itching.

Insulin is a hormone naturally produced in the pancreas that helps the body utilize glucose for energy. In the case of diabetes, where the pancreas does not produce enough insulin or the insulin it makes is ineffective, synthetic insulin such as Human Mixtard 70/30 Suspension for Injection 100IU/ml plays a crucial role. This fast-acting insulin analogue starts working within 10-20 minutes and lasts for 3-5 hours, rapidly normalizing blood sugar levels.

HUMAN MIXTARD 30/70 100IU INJECTION also helps manage blood sugar levels in diabetes patients by improving glycemic control. This medication contains Biphasic Isophane Insulin, a combination of Regular insulin and Isophane insulin. It starts lowering blood sugar levels within 30 minutes of injection, emphasizing the importance of timing in relation to meals.

Before starting therapy with HUMAN MIXTARD 30/70 100IU INJECTION, it is important to consult your doctor, especially if you have underlying health issues such as liver, kidney, or heart problems. Notify your healthcare provider of any hormonal problems, recent dietary changes, or intense exercise routines. Avoid using this medication if you have low blood sugar levels and seek medical advice if you experience side effects like injection site reactions, pain, swelling, or itching that pose concerns.

Both Human Mixtard 70/30 Suspension for Injection 100IU/ml and HUMAN MIXTARD 30/70 100IU INJECTION are essential components of diabetes management, working to regulate blood sugar levels and prevent complications associated with the condition. Proper administration, adherence to prescribed dosages, and close monitoring are crucial for optimizing the effectiveness of these medications in your overall treatment plan.


Disclaimer

The information provided on this website is to the best of our abilities to ensure it is accurate, reliable, and reviewed by a team of professionals. It should not be used to diagnose, prevent, or cure any health problem. The information presented here is not intended to create a doctor-patient relationship or replace a registered medical practitioner's advice, diagnosis, or treatment. The absence or provision of any information or warning regarding any medicine should not be assumed as an implied or explicit assurance of safety or efficacy. We highly recommend consulting your registered medical practitioner for all queries or doubts related to your medical condition. Do not ignore professional medical advice or delay seeking it based on the content encountered on our website. We intend to support, not replace, the doctor-patient relationship.

545.71

Inclusive of all taxes

Content verified by

chevron-right

Dr. Archana Prabhakar

MBBS, M.Med (Family Medicine)

Last update on 07-Oct-2024